Related Articles

• Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline
• Intrahepatic transplantation of adipose‑derived stem cells attenuates the progression of non‑alcoholic fatty liver disease in rats
• Prediction of NAFLD occurrence in prediabetes patients
• Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
• Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review)